1 March 2020
Gero LLC, an AI-powered platform and a drug pipeline for drug discovery and drug repurposing focused on complex diseases and chronic age-related diseases, has signed an agreement to utilize pharmAI’s services to analyze protein-protein interaction along the line of its drug development services.
We are looking forward to a great partnering conference in Hamburg this year. Our CEO Joachim Haupt will present the unique Focused Library Service. With this technology, pharmAI has access to millions of chemical compounds sold be the most popular chemical library vendors.
If you attend BIO-EUROPE, we would be delighted to see you at our talk on Tuesday, November 12 11:00 AM room 3.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.